TrialX
Image

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

Recruiting
13-34 years
All
Phase 4

Overview

Primary Objective:
To explore associations between biomarkers of atopic dermatitis (AD) and:
  • Disease state and time course of AD,
  • Disease state and evolution of selected atopic comorbid conditions,
  • Effectiveness of specific AD treatments.

Description

The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.

Eligibility

Inclusion criteria:
  • Participation in the OBS15333 pediatric atopic dermatitis (AD) registry.
  • Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age.
Exclusion criteria:
Not applicable.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study details
    ATOPIC DERMATITIS
    eczema (atopic dermatitis)
    ATOPIC DERMATITIS
    dermatitis
    atopic
    dermatitis
    atopic
    eczema (atopic dermatitis)

NCT03849716

Sanofi

25 February 2021

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.